73 results on '"Wojdyla, Daniel"'
Search Results
2. Case Volumes and Outcomes Among Early-Career Interventional Cardiologists in the United States
3. Mavacamten for Obstructive Hypertrophic Cardiomyopathy With or Without Hypertension: Post-Hoc Analysis of the EXPLORER-HCM Trial
4. Antithrombotic Strategies According to Age: Insights from the AUGUSTUS Trial
5. Trans-Balance: Reducing demographic disparity for prediction models in the presence of class imbalance
6. Morbidity and Mortality Associated With Heart Failure in Acute Coronary Syndrome: A Pooled Analysis of 4 Clinical Trials
7. Heart rate and death and hospitalization for heart failure in patients with persistent or permanent atrial fibrillation: Insights from the ARISTOTLE trial
8. Outcomes and Institutional Variation in Arterial Access Among Patients With AMI and Cardiogenic Shock Undergoing PCI
9. Comparing the Classification of Percutaneous Coronary Interventions Using the 2012 and 2017 Appropriate Use Criteria: Insights From 245,196 Patients in the NCDR CathPCI Registry
10. Antithrombotic Therapy in Patients With Atrial Fibrillation After Acute Coronary Syndromes or Percutaneous Intervention
11. Contemporary Use of Venoarterial Extracorporeal Membrane Oxygenation: Insights from the Multicenter RESCUE Registry
12. Can the Absence of Hypertension Refine the Risk Assessment of Older Adults for Future Cardiovascular Events?
13. Long-term health-related quality of life and symptom severity following hysterectomy, myomectomy, or uterine artery embolization for the treatment of symptomatic uterine fibroids
14. Association Between Triglycerides and Residual Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus and Established Cardiovascular Disease (From the Bypass Angioplasty Revascularization Investigation 2 Diabetes [BARI 2D] Trial)
15. Prevalence, treatment, and control of severe hyperlipidemia
16. The association between triglycerides and incident cardiovascular disease: What is “optimal”?
17. Impact of Age on Comorbidities and Outcomes in Heart Failure With Reduced Ejection Fraction
18. Characteristics and Outcomes of Atrial Fibrillation in Patients With Thyroid Disease (from the ARISTOTLE Trial)
19. Relationship Between Optimism and Outcomes in Patients With Chronic Angina Pectoris
20. Comparison of Outcomes and Frequency of Graft Failure With Use of Free Versus In Situ Internal Mammary Artery Bypass Conduits (from the PREVENT IV Trial)
21. LB-1 | Temporal Trends and Clinical Outcomes with Radial Versus Femoral Arterial Access for Percutaneous Coronary Intervention in the United States
22. Dual antiplatelet therapy for perioperative myocardial infarction following CABG surgery
23. Digoxin and Mortality in Patients With Atrial Fibrillation
24. Clinical Outcomes and History of Fall in Patients with Atrial Fibrillation Treated with Oral Anticoagulation: Insights From the ARISTOTLE Trial
25. Appropriateness and Outcomes of Percutaneous Coronary Intervention at Top-Ranked and Nonranked Hospitals in the United States
26. Outcomes of Patients with Critical Limb Ischaemia in the EUCLID Trial
27. Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy
28. Anticoagulation therapy and clinical outcomes in patients with recently diagnosed atrial fibrillation: Insights from the ARISTOTLE trial
29. Heart Rate or Beta-Blocker Dose? Association With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction: Results From the HF-ACTION Trial
30. Temporal Trends in Risk Factors of Periprocedural Stroke in Patients Undergoing Percutaneous Coronary Intervention: Insights from the ACC NCDR CathPCI Registry
31. Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures
32. Central venous pressure after coronary artery bypass surgery: Does it predict postoperative mortality or renal failure?
33. Characteristics and Outcomes of Patients With Heart Failure and Discordant Findings by Right-Sided Heart Catheterization and Cardiopulmonary Exercise Testing
34. Comparison of Safety of Sotalol Versus Amiodarone in Patients With Atrial Fibrillation and Coronary Artery Disease
35. Apixaban in patients with atrial fibrillation and prior coronary artery disease: Insights from the ARISTOTLE trial
36. Angiographic Outcomes in the PLATO Trial (Platelet Inhibition and Patient Outcomes)
37. Association of Beta-Blocker Use and Selectivity With Outcomes in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease (from OPTIMIZE-HF)
38. LB-469807-04 EFFICACY AND SAFETY OF APIXABAN VERSUS ASPIRIN ACCORDING TO CHA2DS2-VASC SCORE IN PATIENTS WITH SUBCLINICAL ATRIAL FIBRILLATION IN ARTESIA
39. Hyponatremia and Long-Term Outcomes in Chronic Heart Failure—An Observational Study From the Duke Databank for Cardiovascular Diseases
40. GREATEST ABSOLUTE BENEFIT OF APIXABAN AND LIMITING ASPIRIN IS IN THOSE WITH COMORBIDITY: RESULTS FROM THE AUGUSTUS TRIAL
41. CLINICAL CHARACTERISTICS AND OUTCOMES AMONG ASIANS UNDERGOING ANTITHROMBOTIC THERAPY FOLLOWING ACUTE CORONARY SYNDROME
42. MODIFIED ON-TREATMENT ANALYSIS OF THE EFFECTS OF TORSEMIDE VS FUROSEMIDE AFTER DISCHARGE IN PATIENTS HOSPITALIZED WITH HEART FAILURE: RESULTS FROM TRANSFORM-HF
43. Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial
44. Hospital-Level Percutaneous Coronary Intervention Performance With Simulated Risk Avoidance
45. Misoprostol as an adjunct to standard uterotonics for treatment of post-partum haemorrhage: a multicentre, double-blind randomised trial
46. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study
47. Protective effect of macro and micro nutrients on male lung cancer. A case–control study in Rosario, Argentina
48. TCT-406 Effect of Antithrombotic Strategies on Total Outcome Events in Patients With Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From AUGUSTUS
49. ASSOCIATION OF HRCT PATTERNS AND TRANSPLANT-FREE SURVIVAL IN PATIENTS WITH PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASES (ILDS) IN THE ILD-PRO REGISTRY
50. OBSTRUCTIVE HCM PATIENTS IN EXPLORER-HCM WITH HIGH LEFT VENTRICULAR FILLING PRESSURES HAD MORE SEVERE HEART FAILURE BUT SIMILAR OR GREATER RESPONSE TO MAVACAMTEN
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.